From the Wall Street Journal: Eli Lilly & Co. said Friday its new lung-cancer drug will cost about $11,430 a patient a month in the U. S.—well above what a group of doctors say is a fair price that reflects what they call the drug’s modest benefit.
The Big Pharma company Lilly
is making things awfully chilly
for lung cancer martyrs --
they charge 'em, for starters,
a fortune for drugs willy-nilly.
No comments:
Post a Comment